TROCEPT: A tumor-targeted precision immunovirotherapy enabling αvβ6 integrin-positive tumor-localized expression of an immune checkpoint inhibitor following intravenous delivery.

ATTR-01 - Accession Therap

A. Shibu 1; R. Khanolkar 1; J. Davies 2; A. Baker 3; T. Webb 1; E. Henderson 1; J. Pentier 1; A. Parker 4; D. Cole 5; A. Gerry 3

Jun 17, 2026